FRA:27N0 - Deutsche Boerse Ag - DE000A37FUP2 - Common Stock - Currency: EUR
FRA:27N0 (3/7/2025, 7:00:00 PM)
0.258
-0.01 (-3.73%)
The current stock price of 27N0.DE is 0.258 EUR. In the past month the price decreased by -40%. In the past year, price decreased by -94.94%.
Cannovum Cannabis AG engages in the manufacture, sale, and distribution of medical cannabis. The company is headquartered in Berlin, Berlin. The company went IPO on 2021-05-11. The firm engages as a wholesaler, importer and manufacturer of cannabis-based medicines and provide patients in Germany with medical cannabis. The firm focuses on the import of medical cannabis, medical-scientific education and distribution for facilitated access to cannabis-based therapies.
CANNOVUM CANNABIS AG
Rheinsberger Strasse 76/77
Berlin BERLIN DE
Employees: 0
Company Website: https://www.cannovum.de/
Investor Relations: http://cannovum.com/investor-relations
Phone: 491785811701
The current stock price of 27N0.DE is 0.258 EUR. The price decreased by -3.73% in the last trading session.
The exchange symbol of CANNOVUM CANNABIS AG is 27N0 and it is listed on the Deutsche Boerse Ag exchange.
27N0.DE stock is listed on the Deutsche Boerse Ag exchange.
CANNOVUM CANNABIS AG (27N0.DE) has a market capitalization of 595.98K EUR. This makes 27N0.DE a Nano Cap stock.
CANNOVUM CANNABIS AG (27N0.DE) currently has 0 employees.
CANNOVUM CANNABIS AG (27N0.DE) has a resistance level at 0.45. Check the full technical report for a detailed analysis of 27N0.DE support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
27N0.DE does not pay a dividend.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to 27N0.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.